|
市場調查報告書
抗賀爾蒙療法市場預測
Antihormonal Therapies Market Forecast
|
抗賀爾蒙療法市場預測 是由出版商Datamonitor在2010年07月所出版的。
這份英文市場調查報告書價格從美金15200起跳。
2009年抗賀爾蒙療法的癌症治療藥物品牌，在全球七大醫療藥品市場（美國、日本、法國、德國、義大利、西班牙、英國）達到70億美元的銷售記錄。
本報告針對2009年到2018年主要七個國家的抗賀爾蒙治療藥物做各種分析，提供品牌動向、市場成長促進因素、阻礙因素、品牌藥物的目標等，目錄介紹如下。
概要
- 主要7大國家預測
- 介紹
- 報告範圍
- 調查分析重點
- 閱讀本報告原因
預測方法
Abstract
Introduction
Antihormonal cancer therapies are a class of drugs used predominantly in the treatment of breast cancer and prostate cancer. The high incidence of these tumor types translates into a significant commercial potential for drug developers. Collectively, the antihormonal therapy cancer brands generated sales of about $7.0 billion in the seven major pharmaceutical markets in 2009.
Reasons to Purchase
- Quantify the performance of each of the marketed antihormonal therapy cancer brands in the seven major markets over the period 2009 to 2019
- Acquire a detailed account of antihormonal therapy cancer brand dynamics and the events that drive and limit their market growth
- Benchmark antihormonal therapy cancer brands against their generics and rest of class and align their 7MM performance with a rest of world snapshot
Table of Contents
OVERVIEW
- This product contains forecasts for the antihormonal cancer therapies across the seven major markets from 2009 to 2019. It has been designed for delivery in an excel data pack format.
- The associated report and PowerPoint presentation can be found under Latest research in the Knowledge centre, through the search function or by contacting your sales representative.
- Introduction
- Research and analysis highlights
- Key reasons to read this report
- Forecasting Methodology
- The forecasting model:
- General event information:
- Event selection and quantification:
- Event parameters:
|
